
According to a Bloomberg News report, unsealed court documents show that Johnson & Johnson (NYSE:JNJ) paid for a study that injected ten incarcerated Black men with asbestos as part of the Company's early talcum powder trials.
In one study, inmates were paid to be injected with potentially cancer-causing asbestos so JNJ could compare its effect on their skin versus that of talc, a key component in its baby powder.